Document is current

Article History

Received: 25 July 2025

Accepted: 19 December 2025

First Online: 26 January 2026

Declarations

:

: This study will be conducted in accordance with legal and regulatory requirements, as well as the general principles set forth in the International Ethical Guidelines for Biomedical Research Involving Human Subjects (Council for International Organizations of Medical Sciences, 2002), Guidelines for Good Clinical Practice (International Conference on Harmonization, 1996), and the Declaration of Helsinki (World Medical Association 1996 and 2008). In addition, the study will be conducted in accordance with the protocol, the International Conference on Harmonization Guideline on Good Clinical Practice, and applicable local regulatory requirements and laws (law n°2004-806, August 9th 2004). This protocol obtained a favorable opinion of the Independent Ethics Committee (art. L1123-6 of French Public Health Code), and the National Agency for the Safety of Medicines and Health Products (ANSM) was informed. All participants in the study will sign an informed consent form. Agreement of their legal guardian for patients under guardianship will be asked. The promoter of this research, the Centre Hospitalier du Rouvray, 4 rue Paul Eluard, 76300 Sotteville-lès-Rouen, France, has purchased civil liability insurance from the Société Hospitalière d’Assurance Mutuelle.

: Not applicable.

: The authors declare that they have no competing interests.